Life Sciences & Biotechnology, COVID-19 Technology
Title: | Antisera Bank |
Area: | Life Sciences & Biotechnology, COVID-19 Technology |
Focus Area: | Development of an anti- COVID-19 antisera bank |
Developing Agency: | CSIR-Indian Institute of Chemical Biology (CSIR-IICB), Kolkata |
Technology Readiness Index: | Commercialized |
| Website Link : | https://www.iicb.res.in/ |
Brief Description
Description : | CSIR-IICB has initiated a programme for the development of an anti- COVID-19 antisera bank. Besides, to understand the COVID-19 receptor recognition causing infectivity and pathogenesis, CSIR-IICB compiled a list of 20 probable drug targets on host and virus based on viral life cycle for the rational development of future antivirals. They prepared nine homology models for vital proteins for which no crystal structure is reported, which includes protein from the host, viral membrane proteins and essential Non-structural Proteins (NSPs) of the virus. |
Related Technologies